1. Home
  2. SION

as 04-17-2025 10:42am EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

NYSE

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

Founded: 2019 Country:
United States
United States
Employees: N/A City: WALTHAM
Market Cap: 338.0M IPO Year: 2025
Target Price: $32.00 AVG Volume (30 days): 223.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -15.99 EPS Growth: N/A
52 Week Low/High: $7.26 - $25.19 Next Earning Date: 05-25-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: